Cancer/testis antigen 2
Registration of APIs CMC information required for an IND
IND and NDA support Drug master files (DMF) filing
Synonyms/Alias | Cancer/testis antigen 2 (37-50) |
Sequence | AGATGGRGPRGAGA |
Areas of Interest | Antigen-presenting Cells; Cancer Research |
Source# | Homo sapiens (human) |
Epitope | 37-50 |
Restricting HLA | HLA-DR15 |
References | Hasegawa; Clin Cancer Res 2006 |
1. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
2. The spatiotemporal control of signalling and trafficking of the GLP-1R
3. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us. We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.